A Randomized Phase II Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Zoledronic acid (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 08 Mar 2019 Planned number of patients changed from 40 to 44.
- 08 Mar 2019 Planned End Date changed from 16 Sep 2020 to 1 May 2021.
- 08 Mar 2019 Planned primary completion date changed from 16 Sep 2019 to 1 May 2020.